Welcome to our dedicated page for Sonoco Prod SEC filings (Ticker: SON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Sonoco Products Company filings document the regulatory record of a NYSE-listed packaging manufacturer with no par value common stock. Recent 8-K filings report operating results, annual and quarterly guidance, Regulation FD strategy updates, capital allocation plans and material financing arrangements, including an unsecured delayed-draw term loan facility.
Sonoco's proxy and annual meeting disclosures cover board elections, auditor ratification, shareholder voting results and executive compensation matters. Other current reports record officer transitions and principal accounting officer responsibilities, providing formal disclosure on governance, leadership and reporting controls for the company's packaging business.
Sonoco Products (SON) filed a Form 4 showing officer Ernest D. Haynes reported derivative transactions on 11/03/2025. Two entries list Transaction Code F involving derivative awards tied to common stock.
The first covers Dividend equivalents on Restricted Stock Units with 8 underlying shares at $40.57, leaving 682.3 derivative securities beneficially owned. The second involves Restricted Stock Units with 60 underlying shares at $40.57, with 1,650 derivative securities beneficially owned after the transaction. Each RSU represents a contingent right to receive one share, and dividend equivalent rights settle upon retirement or termination, with RSUs vesting three years from grant.
Sonoco Products Company completed the sale of its ThermoSafe business to Arctic US Bidco, Inc. on November 3, 2025. The transaction totals up to $725,000,000, comprising $650,000,000 paid at closing on a cash‑free, debt‑free basis (subject to customary adjustments) and up to $75,000,000 of additional consideration tied to 2025 performance measures.
The company states that forward‑looking statements related to expected benefits, portfolio simplification, organizational streamlining, and capital investments are subject to risks and uncertainties, including the potential non‑achievement of performance measures for the additional consideration.
Sonoco Products Company completed the sale of its ThermoSafe business to Arctic US Bidco, Inc. on November 3, 2025. The transaction totals up to $725,000,000, comprising $650,000,000 paid at closing on a cash‑free, debt‑free basis (subject to customary adjustments) and up to $75,000,000 of additional consideration tied to 2025 performance measures.
The company states that forward‑looking statements related to expected benefits, portfolio simplification, organizational streamlining, and capital investments are subject to risks and uncertainties, including the potential non‑achievement of performance measures for the additional consideration.
The Vanguard Group filed Amendment No. 12 to Schedule 13G disclosing beneficial ownership of 9,990,310 shares of Sonoco Products (SON) common stock, representing 10.12% of the class as of the event date 09/30/2025.
Vanguard reports 0 shares with sole voting power and 634,035 with shared voting power. It has 9,232,246 shares with sole dispositive power and 758,064 with shared dispositive power. The filing states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
Vanguard notes its clients have rights to dividends and sale proceeds related to the reported securities, and no single other person’s interest exceeds 5%.
Sonoco Products (SON) director John R. Haley reported an open-market purchase of 2,506 shares of common stock on 10/28/2025 at $39.87 per share (Code P). Following the trade, he beneficially owned 23,310 shares directly and 183,497 shares indirectly by spouse.
Sonoco Products (SON) Form 4: the company’s CFO reported open‑market purchases of common stock on 10/29/2025. Transactions coded “P” show acquisitions at prices of $39.50, $39.49, $39.48, $39.46, and $39.44.
Acquired share amounts were 20,317; 75; 75; 23; and 10, bringing beneficial ownership to 20,500 shares directly following the reported transactions.
Sonoco Products Company filed its Q3 2025 report, showing higher sales and profits from continuing operations while advancing portfolio moves. Net sales were $2,131.1 million versus $1,354.7 million a year ago, and operating profit rose to $195.0 million from $102.1 million. Diluted EPS from continuing operations was $1.23 compared with $0.31.
Year to date, net income was $670.8 million, aided by $429.7 million from discontinued operations tied to the April sale of the Thermoformed and Flexibles Packaging and Trident businesses. Operating cash flow was $276.9 million; investing activities provided $1,584.3 million largely from $1,814.9 million of TFP sale proceeds, and financing used $2,090.3 million, including $2,082.9 million of debt repayments. Long‑term debt declined to $3,787.7 million from $4,985.5 million, and shareholders’ equity rose to $3,319.5 million. Sonoco agreed to sell ThermoSafe for up to $725.0 million and classified its assets and liabilities as held for sale. Shares outstanding were 98,633,013 as of October 17, 2025.
Sonoco Products Company reported that it issued a news release covering financial results for the quarter ended September 28, 2025 and provided guidance for full year 2025.
The company furnished the release as Exhibit 99 to a Form 8-K under Item 2.02, with the cover page Inline XBRL included as Exhibit 104.
Blythe J. McGarvie, a director of Sonoco Products Company (SON), had 842.2 phantom stock units accrued under the company’s directors deferred compensation plan on 10/01/2025. Each phantom unit equals one share of Sonoco common stock and the units are recorded at an economic value of $43.04 per share. Following the reported accrual, the filing shows the reporting person beneficially owning 31,374.2 shares. The phantom units are scheduled to be settled in Sonoco common stock six months after the reporting person’s retirement, per the plan terms.
Sonoco Products Co. (SON) director Richard G. Kyle reported an award of 842.2 phantom stock units on 10/01/2025. Each phantom unit is the economic equivalent of one share of Sonoco common stock and the units were accrued under the companys directors deferred compensation plan. The units are to be settled in Sonoco common stock six months after the reporting persons retirement. The filing shows a referenced price of $43.04, and following the reported transaction the reporting person beneficially owns 27,792.5 shares (direct). The Form 4 was signed on 10/02/2025 by Elizabeth R. Kremer as power of attorney for Richard G. Kyle.
Philippe Guillemot, a director of Sonoco Products Co. (SON), reported a transaction dated 10/01/2025 on a Form 4. The filing shows 842.2 phantom stock units were accrued under the company's directors deferred compensation plan; each unit is the economic equivalent of one share of Sonoco common stock. The units carry a reported per‑unit value of $43.04 and are to be settled in Sonoco common stock six months after the reporting person's retirement. After this accrual, the filing reports 26,602.1 shares (or equivalents) beneficially owned by the reporting person. The Form 4 was submitted via power of attorney and dated 10/02/2025.